• Aspect Medical Systems (Norwood, Massachusetts) said that Boudewijn Bollen will retire from his role as president of international operations in 1Q08. After this time, Bollen will serve on a part-time basis as a senior company advisor and will remain a member of the board of directors. Bill Floyd, VP of sales and marketing for Aspect, will work with Bollen throughout a transition period starting in September 2007, and will be promoted to executive VP of worldwide sales and marketing upon Bollen’s retirement. Aspect specializes in brain monitoring technology.

• Richard Gonzalez, president/COO, and a member of Abbott’s (Abbott Park, Illinois) board of directors, plans to retire after a 30-year career with the company. “Rick is a consummate leader and has had a distinguished career at Abbott, including his work to help conceive and execute Abbott’s successful medical products strategy,” said Miles White, CEO/chairman. Gonzalez will remain with Abbott until Sept. 30, 2007. Upon his retirement, the heads of Abbott’s four operating businesses — medical devices, pharmaceuticals, nutritionals and diagnostics — will report directly to White. Abbott specializes in pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

• Scott Bruder, MD, was named senior VP and chief technology officer of BD (Becton, Dickinson and Company; Franklin Lakes, New Jersey), effective Sept. 1. Bruder most recently was the worldwide VP for Johnson & Johnson Regenerative Therapeutics. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines.